Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2002;50(Supplement 4):iv26-iv30; doi:10.1136/gut.50.suppl_4.iv26
Copyright © 2002 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2002;50:iv26-iv30
© 2002 by Gut

DYSPEPSIA MANAGEMENT

Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?

S J O Veldhuyzen van Zanten1, N J Talley2, A L Blum3, E Bolling-Sternevald4, M Sundin5, O Junghard5

1 Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada
2 Department of Medicine, University of Sydney, Nepean Hospital, Penrith, Australia
3 Division of Gastroenterology, Department of Medicine, University Hospital, Lausanne, Switzerland
4 Department of Biomedicine and Surgery, University Hospital, Linköping, Sweden
5 AstraZeneca R&D, Mölndal, Sweden

Correspondence to:
Correspondence to:
Dr S J O Veldhuyzen van Zanten, Division of Gastroenterology, Dalhousie University, Queen Elizabeth II Health Science Centre, Victoria General Site, Room 928, Centennial Building, Halifax, Nova Scotia, Canada B3H 2YG;
zanten{at}is.dal.ca

ABSTRACT

Currently, one of the most important unresolved questions concerning Helicobacter pylori is whether eradication of the organism leads to a sustained improvement in symptoms in patients diagnosed with functional (non-ulcer) dyspepsia. Recently, two very similar studies, the ORCHID and OCAY studies, have been completed and the combined results of these two multicentre, multinational, randomised, double blind, controlled clinical trials are reviewed.

Keywords: clinical trial; dyspepsia; Helicobacter pylori; OCAY study; ORCHID study; quality of life; symptom relief

Abbreviations: GDSS, Glasgow dyspepsia severity score; GORD, gastro-oesophageal reflux disease; GSRS, gastrointestinal symptom rating scale; ITT, intention to treat; MRC, Medical Research Council; OAC, omeprazole 20 mg twice daily, amoxycillin 1000 mg twice daily, and clarithromycin 500 mg twice daily for seven days; PGWB, psychological general well being


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Bercik, P., Verdu, E. F., Foster, J. A., Lu, J., Scharringa, A., Kean, I., Wang, L., Blennerhassett, P., Collins, S. M. (2009). Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R587-R594 [Abstract] [Full Text]  
  • Campbell, D I, Thomas, J E (2005). Helicobacter pylori infection in paediatric practice. EDUCATION AND PRACTICE 90: ep25-ep30 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs